Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Kari Myren
Person

Kari Myren

Tracked across 1 events · 6 articles · First seen Aug 11, 2026 · Last active Aug 11, 2026

Sentiment
20
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 20
Tech
Oncoinvent publishes Radspherin dosimetry results
Oncoinvent, a biotech company developing Radspherin, an alpha radiopharmaceutical for treating peritoneal metastases, announced the publication of clinical dosimetry data in the The Journal of Nuclear Medicine. The publication, titled 'Normal Tissue Dosimetry of Intraperitoneal…
Impact: Kari Myren is the Chief Medical Officer at Oncoinvent and is quoted in the announcement. Her statements reinforce the safety and development potential of Radspherin.
Aug 11, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Kari Myren live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.